Virtu Financial LLC raised its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 111.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 49,094 shares of the pharmacy operator's stock after purchasing an additional 25,920 shares during the period. Virtu Financial LLC's holdings in Walgreens Boots Alliance were worth $458,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Quest Partners LLC raised its holdings in shares of Walgreens Boots Alliance by 379.4% during the third quarter. Quest Partners LLC now owns 10,499 shares of the pharmacy operator's stock worth $94,000 after purchasing an additional 8,309 shares during the period. Intech Investment Management LLC acquired a new stake in Walgreens Boots Alliance during the third quarter worth about $109,000. Charles Schwab Investment Management Inc. grew its holdings in shares of Walgreens Boots Alliance by 43.6% during the third quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator's stock valued at $98,284,000 after purchasing an additional 3,329,857 shares during the last quarter. Great Valley Advisor Group Inc. acquired a new stake in shares of Walgreens Boots Alliance during the 3rd quarter worth approximately $106,000. Finally, Cerity Partners LLC lifted its holdings in shares of Walgreens Boots Alliance by 75.3% in the 3rd quarter. Cerity Partners LLC now owns 672,104 shares of the pharmacy operator's stock worth $6,022,000 after purchasing an additional 288,657 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company's stock.
Analysts Set New Price Targets
WBA has been the subject of a number of analyst reports. Bank of America boosted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a research report on Monday, January 13th. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their target price for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Royal Bank of Canada increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. Evercore ISI upped their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. Finally, Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $10.59.
Check Out Our Latest Report on WBA
Walgreens Boots Alliance Stock Up 0.3 %
Shares of Walgreens Boots Alliance stock traded up $0.03 on Friday, hitting $11.19. 12,142,307 shares of the company traded hands, compared to its average volume of 21,020,253. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $21.74. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The company has a market cap of $9.67 billion, a PE ratio of -1.09, a PEG ratio of 1.31 and a beta of 0.62. The company has a 50-day moving average price of $10.83 and a 200 day moving average price of $9.91.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm's revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.66 EPS. Sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Walgreens Boots Alliance Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
